TORONTO (AP) _ Intellipharmaceutics International Inc. (IPCI) on Tuesday reported a loss of $2 million in its fiscal first quarter.
The Toronto-based company said it had a loss of 7 cents per share.
The extended-release drug developer posted revenue of $1.2 million in the period.
In the final minutes of trading on Tuesday, the company's shares hit $2.05. A year ago, they were trading at $2.18.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IPCI at https://www.zacks.com/ap/IPCI
Keywords: Intellipharmaceutics International, Earnings Report
Your email address will not be published. Required fields are marked *
Information Regarding Meeting Items for Ordinary Shareholders’ Meeting Agenda for CBFI Holders
Buenaventura Announces First Quarter and 2017 Estimated Production per Metal Results